Although the deletions and duplications of the BP1–BP2 region are equally common, the previous studies have reported that the deletions have a more severe impact than duplications (10), with clinical features presenting as cognitive deficits, motor delays, autism spectrum disorder (ASD), ataxia, attention disorders, and seizures (7, 23). The gene discussed is IGFBP2; the disease is Cognitive impairment.